Syntheses of 2-nitroimidazole derivatives conjugated with 1,4,7-triazacyclononane- N, N ′-diacetic acid labeled with F-18 using an aluminum complex method for hypoxia imaging

Journal of Medicinal Chemistry

Volumn 55, Issue 7, 2012, Pages 3155-3162

  Hoigebazar, Lathika ^a   Jeong, Jae Min ^a   Lee, Ji Youn ^a   Shetty, Dinesh ^a   Yang, Bo Yeun ^a   Lee, Yun Sang ^a   Lee, Dong Soo ^a   Chung, June Key ^a   Lee, Myung Chul ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

1,4,7 TRIAZACYCLONONANE 1,4 DIACETIC ACID DERIVATIVE; 1,4,7 TRIAZACYCLONONANE 1,4 DIACETIC ACID ETHYLNITROIMIDAZOLE; 1,4,7 TRIAZACYCLONONANE 1,4 DIACETIC ACID PROPYLNITROIMIDAZOLE; 2 NITROIMIDAZOLE DERIVATIVE; ACETOACETIC ACID DERIVATIVE; ALUMINUM DERIVATIVE; FLUORINE 18; NITROIMIDAZOLE ETHYLBROMIDE; NITROIMIDAZOLE PROPYLBROMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; AQUEOUS SOLUTION; ARTICLE; DRUG CONJUGATION; DRUG SYNTHESIS; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RADIOCHEMISTRY; TUMOR CELL; TUMOR XENOGRAFT;

ALUMINUM; ANIMALS; BLOOD PROTEINS; CELL HYPOXIA; CELL LINE; CELL LINE, TUMOR; COORDINATION COMPLEXES; CRICETINAE; CRICETULUS; FLUORINE RADIOISOTOPES; HETEROCYCLIC COMPOUNDS; HUMANS; IMIDAZOLES; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; NITRO COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 84859806620     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm201611a     Document Type: Article

References (36)

1. Esteban, M. A.; Maxwell, P. H. HIF, a missing link between metabolism and cancer Nature Med. 2005, 11, 1047-1048
2. Overgaard, J. Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors Oncol. Res. 1994, 6, 509-518
3. He, F.; Deng, X.; Wen, B.; Liu, Y.; Sun, X.; Xing, L.; Minami, A.; Huang, Y.; Chen, Q.; Zanzonico, P. B.; Ling, C. C.; Li, G. C. Noninvasive molecular imaging of hypoxia in human xenografts: comparing hypoxia-induced gene expression with endogenous and exogenous hypoxia markers Cancer Res. 2008, 68, 8597-8606
4. Rofstad, E. K.; Sundfor, K.; Lyng, H.; Trope, C. G. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis Br. J. Cancer 2000, 83, 354-359
5. Nordsmark, M.; Overgaard, M.; Overgaard, J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck Radiother. Oncol. 1996, 41, 31-39
6. Lehtio, K.; Eskola, O.; Viljanen, T.; Oikonen, V.; Gronroos, T.; Sillanmaki, L.; Grenman, R.; Minn, H. Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer Int. J. Radiat. Oncol., Biol., Phys. 2004, 59, 971-982
7. Rajendran, J. G.; Schwartz, D. L.; O'Sullivan, J.; Peterson, L. M.; Ng, P.; Scharnhorst, J.; Grierson, J. R.; Krohn, K. A. Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer Clin. Cancer Res. 2006, 12, 5435-5441
8. Whitmore, G. F.; Varghese, A. J. The biological properties of reduced nitroheterocyclics and possible underlying biochemical mechanisms Biochem. Pharmacol. 1986, 35, 97-103
9. 18F]fluoromisonidazole Nucl. Med. Biol. 2005, 32, 553-558
10. 18F]fluoromisonidazole PET and immunohistochemistry Br. J. Cancer 2004, 91, 1947-1954
11. 18F]FMISO in an experimental mammary carcinoma Eur. J. Nucl. Med. Mol. Imaging 2004, 31, 513-520
12. Piert, M.; Machulla, H. J.; Picchio, M.; Reischl, G.; Ziegler, S.; Kumar, P.; Wester, H. J.; Beck, R.; McEwan, A. J.; Wiebe, L. I.; Schwaiger, M. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside J. Nucl. Med. 2005, 46, 106-113
13. 18F-FAZA PET predicts success of hypoxia-directed radiochemotherapy using tirapazamine J. Nucl. Med. 2007, 48, 973-980
14. 18F-EF5: a new PET tracer for imaging hypoxia in head and neck cancer J. Nucl. Med. 2008, 49, 1944-1951
15. 18F-radiolabelling Nucl. Med. Biol. 2009, 36, 895-905
16. Kim, D. W.; Choe, Y. S.; Chi, D. Y. A new nucleophilic fluorine-18 labeling method for aliphatic mesylates: reaction in ionic liquids shows tolerance for water Nucl. Med. Biol. 2003, 30, 345-350
17. Kim, H. W.; Jeong, J. M.; Lee, Y. S.; Chi, D. Y.; Chung, K. H.; Lee, D. S.; Chung, J. K.; Lee, M. C. Rapid synthesis of [F-18]FDG without an evaporation step using an ionic liquid Appl. Radiat. Isot. 2004, 61, 1241-1246
18. 18F] fluoride for aliphatic and aromatic nucleophilic radiolabelling Tetrahedron Lett. 2010, 51, 64-66
19. 18F-fluorination reaction using combined processes of coat-capture-elution and microfluidics Tetrahedron 2011, 67, 2427-2433
20. McBride, W. J.; Sharkey, R. M.; Karacay, H.; D'Souza, C. A.; Rossi, E. A.; Laverman, P.; Chang, C. H.; Boerman, O. C.; Goldenberg, D. M. A Novel Method of F-18 Radiolabeling for PET J. Nucl. Med. 2009, 50, 991-998
21. Laverman, P.; McBride, W. J.; Sharkey, R. M.; Eek, A.; Joosten, L.; Oyen, W. J. G.; Chang, C. H.; Boerman, O. C; Goldenberg, D. M. A Novel Facile Method of Labeling Octreotide with F-18-Fluorine J. Nucl. Med. 2010, 51, 454-461
22. 18F labeling of peptides with a fluoride-aluminum-chelate complex Bioconjugate Chem. 2010, 21, 1331-1340
23. 18F Chelation Bioconjugate Chem. 2011, 22, 1793-1803
24. 68Ga and investigation of in vitro properties Nucl. Med. Mol. Imaging 2009, 43, 330-336
25. 68Ga-Labeling and Testing in Tumor Xenografted Mice J. Med. Chem. 2010, 53, 6378-6385
26. Parker, D. Tumor Targeting with Radiolabeled Macrocycle Antibody Conjugates Chem. Soc. Rev. 1990, 19, 271-291
27. Jeong, J. M.; Hong, M. K.; Chang, Y. S.; Lee, Y. S.; Kim, Y. J.; Cheon, G. J.; Lee, D. S.; Chung, J. K.; Lee, M. C. Preparation of a promising angiogenesis PET imaging agent: Ga-68-labeled c(RGDyK)-isothiocyanatobenzyl-1,4, 7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice J. Nucl. Med. 2008, 49, 830-836
28. 68Ga BAPEN kit for myocardial positron emission tomography imaging and biodistribution study Nucl. Med. Biol. 2010, 37, 149-155
29. 68Ga-labeled DOTA-nitroimidazole derivatives and their feasibilities as hypoxia imaging PET tracers Bioorg. Med. Chem. 2011, 19, 2176-2181
30. 68Ga-labeled mannosylated human serum albumin (MSA) as a lymph node imaging agent for positron emission tomography Nucl. Med. Biol. 2011, 38, 371-379
31. Shetty, D.; Jeong, J. M.; Ju, C. H.; Kim, Y. J.; Lee, J. Y.; Lee, Y. S.; Lee, D. S.; Chung, J. K.; Lee, M. C. Synthesis and evaluation of macrocyclic amino acid derivatives for tumor imaging by gallium-68 positron emission tomography Bioorg. Med. Chem. 2010, 18, 7338-7347
32. 68Ga-labeled amino acid derivatives for positron emission tomography of cancer cells Nucl. Med. Biol. 2010, 37, 893-902
33. 3+ hydrolysis reactions J. Inorg. Biochem. 1991, 44, 141-147
34. - with a third ligand Coord. Chem. Rev. 1996, 149, 23-32
35. 18F-labeling study Chem. Commun. 2011, 47, 9732-9734
36. 18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors Nucl. Med. Biol. 2003, 30, 317-326